In our own field of experimental clinical research, which relies on hospital co-operation and space, things continue to be challenging. As well as the demand on hospital space for the treatment of coronavirus patients that has affected the provision of many specialist services, clinical research facilities have often been requisitioned for COVID-19 vaccine studies, meaning non-COVID work has to some extent been side-lined. Slowly this is improving, however, particularly given the fact that cardiovascular deaths are once again outweighing coronavirus deaths. We, of course, must remember that we were already fighting other global pandemics of cardiovascular, metabolic and malignant disease when COVID-19 struck and should regain focus on these as normality gradually returns.
The ESC Working Group on Thrombosis Young Researchers has continued to disseminate news and facilitate networking through such schemes as our Facebook group and "Paper of the Month". As "in person" conferences become more likely going into 2022, we hope to meet up once again.
Our mission: To reduce the burden of cardiovascular disease.